[Magnesium sulphate against the risk of pre-eclampsia and eclampsia].
Masson
Catherine
C
D000927:Anticonvulsants / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D004461:Eclampsia / Q000188:drug therapy / Q000517:prevention & control*; D005260:Female; D006801:Humans; D007226:Infant Mortality; D007231:Infant, Newborn; D007273:Injections, Intramuscular; D007275:Injections, Intravenous; D008278:Magnesium Sulfate / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D008428:Maternal Mortality; D015337:Multicenter Studies as Topic; D010919:Placebos; D011225:Pre-Eclampsia / Q000188:drug therapy / Q000517:prevention & control*; D011247:Pregnancy; D011644:Puerperal Disorders / Q000188:drug therapy; D016032:Randomized Controlled Trials as Topic; D012307:Risk Factors; D016896:Treatment Outcome
D000927:Anticonvulsants; D010919:Placebos; D008278:Magnesium Sulfate
Du sulfate de magnésium contre le risque de pré-éclampsie et d'éclampsie.